Biophoenix Co., Ltd.

This study is testing whether adding an experimental drug called BPC2001 to standard care can better prevent a serious complication called graft-versus-host disease (GvHD) after a stem cell transplant. The trial will enroll 50 adults with blood cancers who are receiving a transpl…